Escalon Medical (ESMC) Stock Statistics & Valuation Metrics
Total Valuation
Escalon Medical has a market cap or net worth of $1.30M. The enterprise value is -$3340.04T.
- Market Cap
- $1.30M
- Enterprise Value
- -$3340.04T
Share Statistics
Escalon Medical has 7,415,329 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 7,415,329
- Owned by Insiders
- ―
- Owned by Institutions
- 2.44%
Financial Efficiency
Escalon Medical’s return on equity (ROE) is 0.68 and return on invested capital (ROIC) is 0.40%.
- Return on Equity (ROE)
- 0.68
- Return on Assets (ROA)
- 0.44
- Return on Invested Capital (ROIC)
- 0.40%
- Return on Capital Employed (ROCE)
- 0.01
- Revenue Per Employee
- 318.40K
- Profits Per Employee
- 100.32K
- Employee Count
- 40
- Asset Turnover
- 1.40
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Escalon Medical is 0.73. Escalon Medical’s PEG ratio is -0.00.
- PE Ratio
- 0.73
- PS Ratio
- 0.11
- PB Ratio
- 0.23
- Price to FCF
- 0.05
- Price to Operating Cash Flow
- 0.05
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Escalon Medical had revenue of 12.74M and earned 4.01M in profits. Earnings per share was 0.27.
- Revenue
- 12.74M
- Gross Profit
- 5.57M
- Operating Income
- 45.23K
- Pretax Income
- 2.87M
- Net Income
- 4.01M
- EBITDA
- 67.82K
- Earnings Per Share (EPS)
- 0.27
Cash Flow
In the last 12 months, operating cash flow was 29.37M and capital expenditures -4,414, giving a free cash flow of 29.37M billion.
- Operating Cash Flow
- 29.37M
- Free Cash Flow
- 29.37M
- Free Cash Flow per Share
- 3.96
Dividends & Yields
Escalon Medical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 2115.81%
- Earnings Yield
- 289.06%
Stock Price Statistics
- Beta
- 1.82
- 52-Week Price Change
- 16.88%
- 50-Day Moving Average
- 0.17
- 200-Day Moving Average
- 0.18
- Relative Strength Index (RSI)
- 61.79
- Average Volume (3m)
- 14.44K
Financial Position
Escalon Medical as a current ratio of 2.94, with Debt / Equity ratio of 16.44%
- Current Ratio
- 2.94
- Quick Ratio
- -723.04
- Debt to Market Cap
- 0.09
- Net Debt to EBITDA
- -45183.69
- Interest Coverage Ratio
- 6.06
Taxes
In the past 12 months, Escalon Medical has paid 1.14M in taxes.
- Income Tax
- 1.14M
- Effective Tax Rate
- 0.40
Enterprise Valuation
Escalon Medical EV to EBITDA ratio is -87452.32, with an EV/FCF ratio of -104.29.
- EV to Sales
- -240.50
- EV to EBITDA
- -87452.32
- EV to Free Cash Flow
- -104.29
- EV to Operating Cash Flow
- -104.29
Balance Sheet
Escalon Medical has $3.07B in cash and marketable securities with $974.74K in debt, giving a net cash position of $3.06B billion.
- Cash & Marketable Securities
- $3.07B
- Total Debt
- $974.74K
- Net Cash
- $3.06B
- Net Cash Per Share
- $413.26
- Tangible Book Value Per Share
- $0.80
Margins
Gross margin is 43.73%, with operating margin of 0.36%, and net profit margin of 31.51%.
- Gross Margin
- 43.73%
- Operating Margin
- 0.36%
- Pretax Margin
- 22.56%
- Net Profit Margin
- 31.51%
- EBITDA Margin
- 0.28%
- EBIT Margin
- 0.10%
Analyst Forecast
The average price target for Escalon Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- 5.73%
- EPS Growth Forecast
- 25380.00%
